Coordinated transcriptional regulation of bone homeostasis by Ebf1 and Zfp521 in both mesenchymal and hematopoietic lineages

Journal of Experimental Medicine

Volumn 210, Issue 5, 2013, Pages 969-985

  Kiviranta, Riku ^a,b,c   Yamana, Kei ^a,b   Saito, Hiroaki ^a,b   Ho, Daniel K ^a,b   Laine, Julius ^c   Tarkkonen, Kati ^c   Nieminen Pihala, Vappu ^c   Hesse, Eric ^a,b   Correa, Diego ^a,b   Määttä, Jorma ^c   Tessarollo, Lino ^d   Rosen, Evan D ^a   Horne, William C ^a,b   Jenkins, Nancy A ^e   Copeland, Neal G ^e   Warming, Soren ^f   Baron, Roland ^a,b  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d NATIONAL CANCER INSTITUTE   (United States)

^e HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^f GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY B CELL FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR ZFP521; UNCLASSIFIED DRUG; EBF1 PROTEIN, MOUSE; EVI3 PROTEIN, MOUSE; RUNX2 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE; BONE DEFECT; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; GENE DELETION; GENE OVEREXPRESSION; GERM LINE; HAPLOINSUFFICIENCY; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPENIA; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; BONE DEVELOPMENT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GERM CELL; HEMATOPOIETIC SYSTEM; MESODERM; METABOLIC BONE DISEASE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BONE AND BONES; BONE DISEASES, METABOLIC; BONE RESORPTION; CELL LINEAGE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE DELETION; GENE EXPRESSION REGULATION; GERM CELLS; HAPLOINSUFFICIENCY; HEMATOPOIETIC SYSTEM; HOMEOSTASIS; MESODERM; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; PHENOTYPE; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

MLCS; MLOWN;

EID: 84879560631     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20121187     Document Type: Article

References (48)

1. Almeida, M. 2011. Unraveling the role of FoxOs in bone-insights from mouse models. Bone. 49:319-327. http://dx.doi.org/10.1016/j.bone.2011.05.023
2. Bond, H.M., M. Mesuraca, E. Carbone, P. Bonelli, V. Agosti, N. Amodio, G. De Rosa, M. Di Nicola, A.M. Gianni, M.A. Moore, et al. 2004. Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells. Blood. 103:2062-2070. http://dx.doi.org/10.1182/blood-2003-07-2388
3. Boyle, W.J., W.S. Simonet, and D.L. Lacey. 2003. Osteoclast differentiation and activation. Nature. 423:337-342. http://dx.doi.org/10.1038/nature01658
4. Bozec, A., L. Bakiri, M. Jimenez, T. Schinke, M. Amling, and E.F. Wagner. 2010.Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production. J. Cell Biol. 190:1093-1106. http://dx.doi.org/10.1083/jcb.201002111
5. Correa, D., E. Hesse, D. Seriwatanachai, R. Kiviranta, H. Saito, K. Yamana, L. Neff, A. Atfi, L. Coillard, D. Sitara, et al. 2010.Zfp521 is a target gene and key effector of parathyroid hormone-related peptide signaling in growth plate chondrocytes. Dev. Cell. 19:533-546. http://dx.doi.org/10.1016/j.devcel.2010.09.008
6. Fu, Q., R.L. Jilka, S.C. Manolagas, and C.A. O'Brien. 2002. Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMPresponse element-binding protein. J. Biol. Chem. 277:48868-48875. http://dx.doi.org/10.1074/jbc. M208494200
7. Fu, Q., S.C. Manolagas, and C.A. O'Brien. 2006. Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer. Mol. Cell. Biol. 26:6453-6468. http://dx.doi.org/10.1128/MCB.00356-06
8. Glass, D.A. II, P. Bialek, J.D. Ahn, M. Starbuck, M.S. Patel, H. Clevers, M.M. Taketo, F. Long, A.P. McMahon, R.A. Lang, and G. Karsenty. 2005. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell. 8:751-764. http://dx.doi.org/10.1016/j.devcel.2005.02.017
9. Hentges, K.E., K.C. Weiser, T. Schountz, L.S. Woodward, H.C. Morse, and M.J. Justice. 2005. Evi3, a zinc-finger protein related to EBFAZ, regulates EBF activity in B-cell leukemia. Oncogene. 24:1220-1230. http://dx.doi.org/10.1038/sj.onc.1208243
10. Hesse, E., H. Saito, R. Kiviranta, D. Correa, K. Yamana, L. Neff, D. Toben, G. Duda, A. Atfi, V. Geoffroy, et al. 2010.Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. J. Cell Biol. 191:1271-1283. http://dx.doi.org/10.1083/jcb.201009107
11. Hesslein, D.G., J.A. Fretz, Y. Xi, T. Nelson, S. Zhou, J.A. Lorenzo, D.G. Schatz, and M.C. Horowitz. 2009. Ebf1-dependent control of the osteoblast and adipocyte lineages. Bone. 44:537-546. http://dx.doi.org/10.1016/j.bone.2008.11.021
12. Jimenez, M.A., P. Akerblad, M. Sigvardsson, and E.D. Rosen. 2007. Critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade. Mol. Cell. Biol. 27:743-757. http://dx.doi.org/10.1128/MCB.01557-06
13. Kamiya, D., S. Banno, N. Sasai, M. Ohgushi, H. Inomata, K. Watanabe, M. Kawada, R. Yakura, H. Kiyonari, K. Nakao, et al. 2011. Intrinsic transition of embryonic stem-cell differentiation into neural progenitors. Nature. 470:503-509. http://dx.doi.org/10.1038/nature09726
14. Kang, S., P. Akerblad, R. Kiviranta, R.K. Gupta, S. Kajimura, M.J. Griffin, J. Min, R. Baron, and E.D. Rosen. 2012. Regulation of early adipose commitment by Zfp521. PLoS Biol. 10:e1001433. http://dx.doi.org/10.1371/journal.pbio.1001433
15. Karsenty, G., H.M. Kronenberg, and C. Settembre. 2009. Genetic control of bone formation. Annu. Rev. Cell Dev. Biol. 25:629-648. http://dx.doi.org/10.1146/annurev.cellbio.042308.113308
16. Kieslinger, M., S. Folberth, G. Dobreva, T. Dorn, L. Croci, R. Erben, G.G. Consalez, and R. Grosschedl. 2005. EBF2 regulates osteoblast-dependent differentiation of osteoclasts. Dev. Cell. 9:757-767. http://dx.doi.org/10.1016/j.devcel.2005.10.009
17. Kitazawa, R., and S. Kitazawa. 2002. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter. Biochem. Biophys. Res. Commun. 290:650-655. http://dx.doi.org/10.1006/bbrc.2001.6251
18. Koga, T., Y. Matsui, M. Asagiri, T. Kodama, B. de Crombrugghe, K. Nakashima, and H. Takayanagi. 2005. NFAT and Osterix cooperatively regulate bone formation. Nat. Med. 11:880-885. http://dx.doi.org/10.1038/nm1270
19. Kousteni, S. 2011. FoxO1: a molecule for all seasons. J. Bone Miner. Res. 26:912-917. http://dx.doi.org/10.1002/jbmr.306
20. Lagergren, A., R. Månsson, J. Zetterblad, E. Smith, B. Basta, D. Bryder, P. Akerblad, and M. Sigvardsson. 2007. The Cxcl12, periostin, and Ccl9 genes are direct targets for early B-cell factor in OP-9 stroma cells. J. Biol. Chem. 282:14454-14462. http://dx.doi.org/10.1074/jbc. M610263200
21. Lanske, B., P. Divieti, C.S. Kovacs, A. Pirro, W.J. Landis, S.M. Krane, F.R. Bringhurst, and H.M. Kronenberg. 1998. The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands in murine bone. Endocrinology. 139:5194-5204. http://dx.doi.org/10.1210/en.139.12.5194
22. Lean, J.M., C. Murphy, K. Fuller, and T.J. Chambers. 2002. CCL9/MIP- 1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts. J. Cell. Biochem. 87:386-393. http://dx.doi.org/10.1002/jcb.10319
23. Lin, H., and R. Grosschedl. 1995. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature. 376:263-267. http://dx.doi.org/10.1038/376263a0
24. Liu, P., N.A. Jenkins, and N.G. Copeland. 2003. A highly efficient recombineering- based method for generating conditional knockout mutations. Genome Res. 13:476-484. http://dx.doi.org/10.1101/gr.749203
25. Lukin, K., S. Fields, J. Hartley, and J. Hagman. 2008. Early B cell factor: Regulator of B lineage specification and commitment. Semin. Immunol. 20:221-227. http://dx.doi.org/10.1016/j.smim.2008.07.004
26. MacDonald, B.T., K. Tamai, and X. He. 2009. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell. 17:9-26. http://dx.doi.org/10.1016/j.devcel.2009.06.016
27. Maruyama, Z., C.A. Yoshida, T. Furuichi, N. Amizuka, M. Ito, R. Fukuyama, T. Miyazaki, H. Kitaura, K. Nakamura, T. Fujita, et al. 2007. Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Dev. Dyn. 236:1876-1890. http://dx.doi.org/10.1002/dvdy.21187
28. Matsubara, E., I. Sakai, J. Yamanouchi, H. Fujiwara, Y. Yakushijin, T. Hato, K. Shigemoto, and M. Yasukawa. 2009. The role of zinc finger protein521/early hematopoietic zinc finger protein in erythroid cell differentiation. J. Biol. Chem. 284:3480-3487. http://dx.doi.org/10.1074/jbc. M805874200
29. Mega, T., M. Lupia, N. Amodio, S.J. Horton, M. Mesuraca, D. Pelaggi, V. Agosti, M. Grieco, E. Chiarella, R. Spina, et al. 2011. Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitors. Cell Cycle. 10: 2129-2139. http://dx.doi.org/10.4161/cc.10.13.16045
30. Nakashima, T., M. Hayashi, T. Fukunaga, K. Kurata, M. Oh-Hora, J.Q. Feng, L.F. Bonewald, T. Kodama, A. Wutz, E.F. Wagner, et al. 2011. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 17:1231-1234. http://dx.doi.org/10.1038/nm.2452
31. Negishi-Koga, T., and H. Takayanagi. 2009. Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol. Rev. 231:241-256. http://dx.doi.org/10.1111/j.1600-065X.2009.00821.x
32. Okamatsu, Y., D. Kim, R. Battaglino, H. Sasaki, U. Späte, and P. Stashenko. 2004. MIP-1 gamma promotes receptor-activator-of-NF-kappa-Bligand- induced osteoclast formation and survival. J. Immunol. 173: 2084-2090.
33. Otero, K., M. Shinohara, H. Zhao, M. Cella, S. Gilfillan, A. Colucci, R. Faccio, F.P. Ross, S.L. Teitelbaum, H. Takayanagi, and M. Colonna. 2012. TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis. J. Immunol. 188:2612-2621. http://dx.doi.org/10.4049/jimmunol.1102836
34. Otto, F., A.P. Thornell, T. Crompton, A. Denzel, K.C. Gilmour, I.R. Rosewell, G.W. Stamp, R.S. Beddington, S. Mundlos, B.R. Olsen, et al. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 89:765-771. http://dx.doi.org/10.1016/S0092-8674(00)80259-7
35. Rodda, S.J., and A.P. McMahon. 2006. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development. 133:3231-3244. http://dx.doi.org/10.1242/dev.02480
36. Sabatakos, G., N.A. Sims, J. Chen, K. Aoki, M.B. Kelz, M. Amling, Y. Bouali, K. Mukhopadhyay, K. Ford, E.J. Nestler, and R. Baron. 2000. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat. Med. 6:985-990. http://dx.doi.org/10.1038/79683
37. Sigvardsson, M. 2000. Overlapping expression of early B-cell factor and basic helix-loop-helix proteins as a mechanism to dictate B-lineage-specific activity of the lambda5 promoter. Mol. Cell. Biol. 20:3640-3654. http://dx.doi.org/10.1128/MCB.20.10.3640-3654.2000
38. Takahashi, N., H. Yamana, S. Yoshiki, G.D. Roodman, G.R. Mundy, S.J. Jones, A. Boyde, and T. Suda. 1988. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology. 122:1373-1382. http://dx.doi.org/10.1210/endo-122-4-1373
39. Wan, Y. 2010.PPARγ in bone homeostasis. Trends Endocrinol. Metab. 21:722-728. http://dx.doi.org/10.1016/j.tem.2010.08.006
40. Warming, S., P. Liu, T. Suzuki, K. Akagi, S. Lindtner, G.N. Pavlakis, N.A. Jenkins, and N.G. Copeland. 2003. Evi3, a common retroviral integration site in murine B-cell lymphoma, encodes an EBFAZ-related Krüppel-like zinc finger protein. Blood. 101:1934-1940. http://dx.doi.org/10.1182/blood-2002-08-2652
41. Warming, S., R.A. Rachel, N.A. Jenkins, and N.G. Copeland. 2006. Zfp423 is required for normal cerebellar development. Mol. Cell. Biol. 26:6913-6922. http://dx.doi.org/10.1128/MCB.02255-05
42. Wei, W., D. Zeve, J.M. Suh, X. Wang, Y. Du, J.E. Zerwekh, P.C. Dechow, J.M. Graff, and Y. Wan. 2011. Biphasic and dosage-dependent regulation of osteoclastogenesis by β-catenin. Mol. Cell. Biol. 31:4706-4719. http://dx.doi.org/10.1128/MCB.05980-11
43. Woitge, H., J. Harrison, A. Ivkosic, Z. Krozowski, and B. Kream. 2001. Cloning and in vitro characterization of alpha 1(I)-collagen 11 betahydroxysteroid dehydrogenase type 2 transgenes as models for osteoblastselective inactivation of natural glucocorticoids. Endocrinology. 142: 1341-1348. http://dx.doi.org/10.1210/en.142.3.1341
44. Wu, M., E. Hesse, F. Morvan, J.P. Zhang, D. Correa, G.C. Rowe, R. Kiviranta, L. Neff, W.M. Philbrick, W.C. Horne, and R. Baron. 2009. Zfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo. Bone. 44:528-536. http://dx.doi.org/10.1016/j.bone.2008.11.011
45. Xiong, J., M. Onal, R.L. Jilka, R.S. Weinstein, S.C. Manolagas, and C.A. O'Brien. 2011. Matrix-embedded cells control osteoclast formation. Nat. Med. 17:1235-1241. http://dx.doi.org/10.1038/nm.2448
46. Yang, X., and G. Karsenty. 2004. ATF4, the osteoblast accumulation of which is determined post-translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells. J. Biol. Chem. 279:47109-47114. http://dx.doi.org/10.1074/jbc. M410010200
47. Yang, X., K. Matsuda, P. Bialek, S. Jacquot, H.C. Masuoka, T. Schinke, L. Li, S. Brancorsini, P. Sassone-Corsi, T.M. Townes, et al. 2004. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell. 117:387-398. http://dx.doi.org/10.1016/S0092-8674(04)00344-7
48. Zhang, M., S. Xuan, M.L. Bouxsein, D. von Stechow, N. Akeno, M.C. Faugere, H. Malluche, G. Zhao, C.J. Rosen, A. Efstratiadis, and T.L. Clemens. 2002. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J. Biol. Chem. 277:44005-44012. http://dx.doi.org/10.1074/jbc. M208265200